ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy

Update Il y a 4 ans
Reference: NCT00816049

Woman and Man

Extract

The purpose of this study is to increase the fraction of patients, who become MRD-negative during consolidation for the non-HR ALL group through individualized intensification of the 6MP-dosage days 30-85.


Inclusion criteria

  • Acute Lymphoblastic Leukemia


Links